Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
LUMICKS logo — Empowering scientists with tools that reveal crucial insight...

LUMICKS

Empowering scientists with tools that reveal crucial insights not available before, at the molecular and cellular level.

Founded 2014 The Netherlands The Netherlands 168 employees Debt Financing Total: $77.85M Biotechnology, Life Sciences +1

General Information

Company Name LUMICKS
Founded Year 2014
Location The Netherlands The Netherlands +3
Employees 168
Industries Biotechnology, Life Sciences, Medical Devices
Funding Stage Debt Financing
Social

Get notified when LUMICKS moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About LUMICKS

LUMICKS is a leading provider of dynamic single-molecule and cell avidity analysis instruments, aiming to empower scientists with tools that reveal crucial insights at the molecular and cellular level. Leveraging innovative and Nobel Prize-winning technologies, such as optical tweezers and STED super-resolution, the company's instruments enable the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells, contributing to a deeper understanding of life at its smallest scale. Founded in 2014, LUMICKS operates within the Biotechnology, Life Sciences, and Medical Devices industries, with its headquarters located in The Netherlands. The company's latest investment, a Debt Financing round, was secured on 10th October 2024. Despite the absence of specific investor details, this investment signifies confidence in LUMICKS' innovative solutions. The company's focus on advancing science and improving human health by providing tools that unlock the measurement of forces and interactions in biology demonstrates its commitment to making meaningful contributions to the field. By directly linking structural and ‘omics analysis to functional outcomes at both a molecular and cellular level, LUMICKS' unparalleled solutions offer the potential to revolutionize research by enabling detailed real-time analysis of underlying biological mechanisms.

Taxonomy: Life Sciences, Cell Biology, Molecular Biology, Single-Molecule Analysis, Cell Avidity Analysis, Optical Tweezers, Fluorescence Microscopy, Microfluidics, Acoustic Force Spectroscopy, Cancer Research, Immune Cell Analysis, Biological Mechanisms, Real-time Analysis

Services & Products

dynamic single-molecule analysis
cell avidity analysis
real-time analysis tools

Target Customers

academic researchers pharmaceutical researchers medical research institutions

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• - 10 Oct 2024
Series D •••••• 8
Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		16 Apr 2021
Series A •••••• 1
Investor
01 Jan 2017
Grant •••••• 1 •••• •••• 01 May 2015
Grant •••••• - 14 Jan 2015

View All 6 Funding Rounds

Latest News

View All
EU backs Dutch scaleup Lumicks to fast-track discovery of cancer treatments — Thenextweb
EU backs Dutch scaleup Lumicks to fast-track discovery of cancer treatments
Thenextweb Oct 12, 2024

LUMICKS Alternatives & Competitors

LUMICKS vs
Samplix
Samplix Denmark

Reveal cell function with single-cell resolution.

Series Unknown
35 employees
Biotechnology, Information Technology
Compare LUMICKS vs Samplix
LUMICKS vs
Bruker Biosensors
Bruker Biosensors Germany

Bruker Biosensors provides analytical systems for the characterization of biomolecules and molecular...

Series A
61 employees
Biopharma, Biotechnology
Compare LUMICKS vs Bruker Biosensors
LUMICKS vs
Honeycomb Biotechnologies
Honeycomb Biotechnologies United States

Any cell. Any where. Any time.

9 employees
Biotechnology
Also compare with: LUMICKS vs LumaCyte LumaCyte

FAQ About LUMICKS

Empowering scientists with tools that reveal crucial insights not available before, at the molecular and cellular level.
LUMICKS was founded in 2014.
LUMICKS is headquartered in The Netherlands.
LUMICKS operates in the following industries: Biotechnology, Life Sciences, Medical Devices.
LUMICKS has approximately 168 employees.
LUMICKS has completed 6 funding rounds, raising a total of $77.85M. The latest funding stage is Debt Financing.
LUMICKS offers: dynamic single-molecule analysis, cell avidity analysis, real-time analysis tools.
Top alternatives and competitors to LUMICKS include Samplix, Bruker Biosensors, Honeycomb Biotechnologies, Cellanome, LumaCyte. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
LUMICKS and Samplix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors LUMICKS and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy